View Older Stories View More Recent Stories

Apr 23, 2025 04:14AM Chardan Capital Markets Starts Tourmaline Bio (TRML) at Buy
Apr 22, 2025 04:05PM Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
Apr 16, 2025 08:00AM Japan Go IPO Summit Announces Roster of Expert Speakers for Event June 5th in Tokyo
Apr 16, 2025 08:00AM /C O R R E C T I O N -- Marcum Asia CPAs LLP/
Apr 16, 2025 01:12AM Chardan Capital Markets Starts Korro Bio Inc. (KRRO) at Buy
Apr 14, 2025 09:27AM Kodiak to Go Public Via Business Combination With Ares Acquisition Corporation II (AACT)
Apr 14, 2025 08:00AM Kodiak, a Leading Provider of AI-Powered Autonomous Vehicle Technology, to Go Public Via Business Combination With Ares Acquisition Corporation II
Apr 10, 2025 06:58PM Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
Apr 9, 2025 11:00AM Centri Announces Sponsors for Capital Conference at Nasdaq on April 22
Apr 9, 2025 06:13AM Chardan Capital Markets Starts Palvella Therapeutics (PVLA) at Buy
Apr 1, 2025 08:06AM Chardan Capital Markets Assumes uniQure BV (QURE) at Buy, PT $38
Mar 27, 2025 08:03AM Chardan Capital Markets Reiterates Neutral Rating on Allurion Technologies (ALUR)
Mar 26, 2025 07:57AM Zura Bio Ltd. (ZURA) PT Lowered to $10 at Chardan Capital Markets
Mar 24, 2025 09:00AM Japan Go IPO Summit Provides Roadmap for Japanese Companies Seeking to List on U.S. Exchanges
Mar 20, 2025 07:00AM Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Mar 20, 2025 06:28AM Prime Medicine (PRME) PT Lowered to $16 at Chardan Capital Markets
Mar 18, 2025 08:53AM Vincerx Pharma (VINC) Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
Mar 18, 2025 08:52AM Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
Mar 17, 2025 07:53AM Chardan Capital Markets Reiterates Buy Rating on Dyne Therapeutics (DYN)
Mar 12, 2025 04:39PM Chardan Capital Markets Upgrades CervoMed (CRVO) to Buy
Mar 4, 2025 04:13PM Passage Bio Inc. (PASG) PT Lowered to $6 at Chardan Capital Markets
Mar 4, 2025 08:07AM Instinct Brothers to Go Public via Merger with Relativity Acquisition Corp (BIOT)
Mar 4, 2025 08:00AM Instinct Brothers Co., Ltd, a Japanese Vertically Integrated Regenerative Medicine & Stem Cell Technology Company, to Go Public via Merger with Relativity Acquisition Corp.
Mar 4, 2025 08:00AM Instinct Brothers Co., Ltd, a Japanese Vertically Integrated Regenerative Medicine & Stem Cell Technology Company, to Go Public via Merger with Relativity Acquisition Corp.
Feb 27, 2025 07:00AM Dragonfly Energy Holdings (DFLI) Announces Corporate Debt Restructuring and Capital Raise
Feb 27, 2025 07:00AM Dragonfly Energy Announces Corporate Debt Restructuring and Capital Raise
Feb 26, 2025 05:00PM Urgently Announces Capital Structure Improvements and Secures up to $20 Million in New Financing
Feb 25, 2025 08:02AM Senti Biosciences (SNTI) Strengthens Leadership Team with Strategic Hires
Feb 25, 2025 08:00AM Senti Bio Strengthens Leadership Team with Strategic Hires
Feb 24, 2025 07:02AM Eyenovia Inc (EYEN) Announces Debt Restructuring Including Amendment to Senior Secured Debt
Feb 24, 2025 07:00AM Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Feb 18, 2025 01:00PM Form SEC STAFF ACTION CHARDAN NEXTECH ACQUISIT
Feb 11, 2025 09:00AM Centri Capital Conference at Nasdaq Approaches
Feb 11, 2025 07:46AM Chardan Capital Markets Reiterates Buy Rating on Arrowhead Pharma (ARWR)
Jan 29, 2025 11:25PM Chardan Capital Markets Downgrades Cargo Therapeutics (CRGX) to Neutral
Jan 10, 2025 07:10AM Chardan Capital Markets Starts Unity Biotechnology Inc (UBX) at Buy
Jan 8, 2025 07:06AM uniQure (QURE) Prices 4.41M Share Offering at $17/sh
Jan 8, 2025 07:05AM uniQure Announces Pricing of its Public Offering
Jan 6, 2025 07:01AM Eyenovia (EYEN) Engages Chardan as Advisor for Review of Strategic Alternatives
Jan 6, 2025 07:00AM Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives
Dec 13, 2024 08:02AM Chardan Capital Markets Downgrades Editas Medicine (EDIT) to Neutral
Dec 11, 2024 02:32AM Chardan Capital Markets Downgrades CervoMed (CRVO) to Neutral
Dec 9, 2024 03:43PM Sonnet BioTherapeutics (SONN) Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 9, 2024 03:42PM Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 6, 2024 08:00AM Eyenovia Inc (EYEN) Prices 20.09M Share Offering at $0.0969
Dec 6, 2024 08:00AM Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering
Dec 4, 2024 05:30PM Ace Green Recycling, a Global Leader in Battery Recycling Technology, to Become a Public Company
Dec 4, 2024 05:30PM /C O R R E C T I O N -- ACE Green Recycling/
Dec 4, 2024 06:54AM Senti Biosciences, Inc. (SNTI) PT Raised to $12 at Chardan Capital Markets
Dec 2, 2024 03:49AM Chardan Capital Markets Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral
View More Recent Stories View Older Stories